Veterinary medicines · Animal health products


17 March, 2020

COVID-19 corporate statement (17/03/2020)

In order to comply with Real Decreto 463/2020, March 14, declaring the state of alarm for the management of the health crisis situation caused by COVID-19, MAYMÓ Group has established an action plan since yesterday, March 16, 2020, thanks to which all measures requested by the authorities are being implemented. Due to the speed of events, a crisis committee is in charge of reviewing the situation daily.

6 June, 2019

At the 44th ASESCU Symposium

The 44º ASESCU Symposium (Spanish Rabbit Association) has been organized this year in Aranda de Duero (Burgos) June 5-6.
14 March, 2019

Launch of Neoiven in different EU countries

Neoiven 500.000 UI/g is the new oral neomycin from Iven for the international market. It has been recently authorized in seven EU member countries. Its launch is imminent in several markets.